# Haemate HS in Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis

> **NCT00618293** · PHASE2 · WITHDRAWN · sponsor: **Heinrich-Heine University, Duesseldorf**

## Conditions studied

- Blood Loss, Surgical

## Interventions

- **DRUG:** Haemate HS
- **OTHER:** NaCl-solution

## Key facts

- **NCT ID:** NCT00618293
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-01
- **Primary completion:** 2010-07
- **Final completion:** 2011-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patient met the criteria for inclusion in the study.
- **Last updated:** 2012-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00618293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00618293, "Haemate HS in Patients With Severe Bleeding Undergoing Valve Replacement Due to Aortic Stenosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00618293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*